Sanotize Research and Development Corp.   Report issue

For profit Phase 2 Phase 3
Founded: Vancouver Canada (2017)

Organization Overview

First Clinical Trial
2019
NCT04163978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sanotize Research and Development corp.